Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Couch

Surgical Critical Care Tyler, TX Medical Doctor

NPI 1831488352 CMS profile 1290780

1000 S Beckham Ave, Tyler, TX 75701

Open in the dashboard

General payments

$30,295

117 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Couch of Tyler, TX is reported in the CMS Open Payments database as having received $30,295 across 117 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $873 25
2024 General $179 5
2023 General $4,759 22
2022 General $5,753 19
2021 General $211 4
2020 General $81 6
2019 General $18,440 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Couch
  • Surgical Critical Care median
  • Middle half of Surgical Critical Care
  • National median

In program year 2025, general payments to Christopher Couch were reported at $873. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.

Show as a table
Year Christopher Couch Surgical Critical Care median Middle half National median
2019 $18,440 $161 $57–$631 $163
2020 $81 $116 $33–$383 $114
2021 $211 $121 $37–$475 $132
2022 $5,753 $163 $53–$789 $149
2023 $4,759 $188 $67–$1,031 $160
2024 $179 $216 $80–$1,133 $164
2025 $873 $231 $82–$1,489 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Avanos Medical $28,026 27 payments
  2. Abiomed $791 24 payments
  3. Abbott Laboratories $742 33 payments
  4. Edwards Lifesciences Corporation $136 1 payment
  5. Merck Sharp & Dohme Corporation $115 8 payments
  6. Teleflex LLC $97 2 payments
  7. Allergan Inc. $81 4 payments
  8. Pfizer Inc. $53 4 payments
  9. KCI USA, Inc $41 2 payments
  10. Inari Medical, Inc. $29 1 payment
  11. Other $184 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $16,137 5 payments
  2. Honoraria $7,678 4 payments
  3. Travel and Lodging $3,709 10 payments
  4. Food and Beverage $2,759 97 payments
  5. Education $13 1 payment
Products named General payments · program years 2019–2025
  1. ON-Q* PUMP AND ACCESSORIES $19,648 19 payments
  2. ON-Q $8,379 8 payments
  3. 2ND GEN CENTRIMAG PRIMARY CONSOLE Heart failure $487 20 payments
  4. Impella $245 11 payments
  5. 2ND GEN CENTRIMAG PRIMARY CONSOLE Structural Heart $153 7 payments
  6. ZERBAXA $115 8 payments
  7. VSI $97 2 payments
  8. STRATTICE $81 4 payments
  9. CentriMag $61 3 payments
  10. CT THROMBECTOMY SYSTEM KIT $55 2 payments
  11. Other $412 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$11,989

Medicare's payments for the services billed

Medicare patients

33

Average age 72

Services billed

88

11 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 70%
Heart failure 70%
Ischemic heart disease 70%
COPD 58%
Atrial fibrillation 55%
Chronic kidney disease 52%
Arthritis 45%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Critical Care in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record